THRX has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
THRX has been removed from your Stock Email Alerts list.
|
Ticker![]() | Guru | Date
|
Action |
Impact
![]() |
Price Range (Average)*
![]() |
Current Price | Change from Average![]() |
Comment | Current Shares | |
|---|---|---|---|---|---|---|---|---|---|---|
| THRX | Jean-Marie Eveillard | 2012-06-30 | Add | 0.01% | $17.51 - $23.63 ($20.75) | $ 37.01 | 78% | Add 24.23% | 509,710 | |
| THRX | Seth Klarman | 2012-03-31 | Add | 0.22% | $16.39 - $20.2 ($17.26) | $ 37.01 | 114% | Add 2.3% | 14,553,800 | |
| THRX | Jean-Marie Eveillard | 2012-03-31 | Add | 0.01% | $16.39 - $20.2 ($17.26) | $ 37.01 | 114% | Add 25.59% | 410,310 | |
| THRX | Seth Klarman | 2011-09-30 | Add | 0.84% | $17.44 - $24.87 ($20.77) | $ 37.01 | 78% | Add 9.76% | 14,225,961 | |
| THRX | Julian Robertson | 2011-09-30 | Sold Out | -1.2512% | $17.44 - $24.87 ($20.77) | $ 37.01 | 78% | Sold Out | 0 | |
| THRX | John Griffin | 2011-06-30 | Sold Out | $21.18 - $28.7 ($24.82) | $ 37.01 | 49% | Sold Out | 0 | ||
| THRX | Jean-Marie Eveillard | 2011-06-30 | Reduce | -0.02% | $21.18 - $28.7 ($24.82) | $ 37.01 | 49% | Reduce -33.79% | 326,710 | |
| THRX | Jean-Marie Eveillard | 2011-03-31 | Add | 0.02% | $20.98 - $25.78 ($23.32) | $ 37.01 | 59% | Add 51.02% | 493,410 | |
| THRX | Wilbur Ross | 2011-03-31 | Sold Out | $20.98 - $25.78 ($23.32) | $ 37.01 | 59% | Sold Out | 0 | ||
| THRX | Julian Robertson | 2011-03-31 | Reduce | -0.35% | $20.98 - $25.78 ($23.32) | $ 37.01 | 59% | Reduce -20.94% | 211,686 | |
| THRX | Wilbur Ross | 2010-12-31 | Buy | 0.13% | $20 - $28.64 ($23.37) | $ 37.01 | 58% | New holding, 45219 sh. | 45,219 | |
| THRX | Julian Robertson | 2010-09-30 | Buy | 1.94% | $11.83 - $19.86 ($14.79) | $ 37.01 | 150% | New holding, 287763 sh. | 287,763 | |
| THRX | John Griffin | 2010-06-30 | Buy | 0.14% | $12.52 - $17.15 ($14.66) | $ 37.01 | 152% | New holding, 620000 sh. | 620,000 | |
| THRX | Seth Klarman | 2010-03-31 | Add | 2.36% | $9.7 - $13.85 ($12.13) | $ 37.01 | 205% | Add 28.71% | 13,000,000 | |
| THRX | Seth Klarman | 2009-12-31 | Add | 1.03% | $13 - $15.4 ($14.08) | $ 37.01 | 163% | Add 11.8% | 10,100,000 | |
| THRX | Jean-Marie Eveillard | 2009-09-30 | Add | 0.01% | $13.13 - $18.38 ($15.14) | $ 37.01 | 144% | Add 39% | 295,100 | |
| THRX | Jean-Marie Eveillard | 2009-06-30 | Buy | 0.03% | $12.94 - $17.6 ($14.47) | $ 37.01 | 156% | New holding, 212300 sh. | 212,300 | |
| THRX | Seth Klarman | 2008-12-31 | Add | 3.09% | $5.77 - $11.77 ($8.5) | $ 37.01 | 335% | Add 44.08% | 9,033,741 | |
| THRX | Seth Klarman | 2008-06-30 | Add | 0.56% | $11.86 - $13.77 ($12.9) | $ 37.01 | 187% | Add 17.66% | 6,269,891 | |
| THRX | Seth Klarman | 2008-03-31 | Buy | 3.41% | $9.4 - $22.18 ($16.3) | $ 37.01 | 127% | New holding, 5328598 sh. | 5,328,598 | |
| | ||||||||||
| Ticker | Guru Name | Portfolio Date* | Current Shares | % of Shares Outstanding | % of Total Assets Managed | Change from Last Holdings | Holding History |
|---|---|---|---|---|---|---|---|
| THRX | Jean-Marie Eveillard | 2013-03-31 | 464,010 | 0.47 | 0.04 | ||
| THRX | Seth Klarman | 2013-03-31 | 13,553,800 | 13.77 | 10.3 |
Most recent portfolio changes are included for Premium Members only!THRX: Insider Buys/Sells Click Here for All Insider Trades. |
| Insider | Position | Date | Trades | Shares | Trade Price ($) | Change (%) | Details |
|---|---|---|---|---|---|---|---|
| Brinkley David L | Head of Business Dev. | 2013-05-13 | Sell | 16,129 | $40.33 | -6.52 | view |
| Brinkley David L | Head of Business Dev. | 2013-05-03 | Sell | 16,129 | $34.77 | 8.43 | view |
| GLAXOSMITHKLINE PLC | 10% Owner | 2013-04-30 | Buy | 193,563 | $6699220 | -100 | view |
| Mammen Mathai | SVP, Research & Early Clin Dev | 2013-04-30 | Sell | 7,000 | $33.74 | 11.74 | view |
| Brinkley David L | Head of Business Dev. | 2013-04-30 | Sell | 17,104 | $33.76 | 11.67 | view |
| Aguiar Michael W | Sr VP, CFO | 2013-04-30 | Sell | 170,879 | $33.8 | 11.54 | view |
| Winningham Rick E | CEO | 2013-04-30 | Sell | 255,532 | $33.64 | 12.07 | view |
| Mammen Mathai | SVP, Research & Early Clin Dev | 2013-02-20 | Sell | 7,000 | $22.14 | 70.28 | view |
| GLAXOSMITHKLINE PLC | 10% Owner | 2013-02-15 | Buy | 116,527 | $2567090 | -100 | view |
| GLAXOSMITHKLINE PLC | 10% Owner | 2012-11-02 | Buy | 280,348 | $6265780 | -100 | view |
Add Notes, Comments or Ask Questions
Comments